These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 3976285)

  • 1. [Reactivity, safety and immunogenicity of trivalent subunit highly purified 'Grippovak SE-AZh' influenza vaccine tested on young children in children's homes in Moscow].
    Chumakov MP; Malyshkina LP; Zhivin IuN; Dobrokhotova LP; Kontareva MG
    Vestn Akad Med Nauk SSSR; 1985; (1):3-9. PubMed ID: 3976285
    [No Abstract]   [Full Text] [Related]  

  • 2. [Studies on the reactivity, safety and immunogenicity of the polyvalent subunit "Grippovak SE-Azh" influenza vaccine in boarding houses for the elderly and disabled].
    Beregovskiĭ NA; Malyshkina LP; Serdiukova LP; Belousova NI; Velikiĭ VN
    Vestn Akad Med Nauk SSSR; 1985; (1):9-12. PubMed ID: 3156457
    [No Abstract]   [Full Text] [Related]  

  • 3. [Results of coded trials of the activity of the trivalent subunit influenza vaccine Grippovak in Moscow kindergartens in December 1983 through the 1st quarter of 1984].
    Chumakov MP; Boĭko VM; Malyshkina LP; Mel'nikova SK; Rodin VI
    Vopr Virusol; 1987; 32(2):175-83. PubMed ID: 3300032
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of inactivated influenza vaccine in children.
    Wright PF
    Semin Pediatr Infect Dis; 2006 Oct; 17(4):200-5. PubMed ID: 17055371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the safety, reactogenicity and immunogenicity of FluBlok trivalent recombinant baculovirus-expressed hemagglutinin influenza vaccine administered intramuscularly to healthy children aged 6-59 months.
    King JC; Cox MM; Reisinger K; Hedrick J; Graham I; Patriarca P
    Vaccine; 2009 Nov; 27(47):6589-94. PubMed ID: 19716456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety, efficacy, and effectiveness of cold-adapted influenza vaccine-trivalent against community-acquired, culture-confirmed influenza in young children attending day care.
    Vesikari T; Fleming DM; Aristegui JF; Vertruyen A; Ashkenazi S; Rappaport R; Skinner J; Saville MK; Gruber WC; Forrest BD;
    Pediatrics; 2006 Dec; 118(6):2298-312. PubMed ID: 17142512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influenza vaccine in healthy preschool children.
    Colombo C; Argiolas L; La Vecchia C; Negri E; Meloni G; Meloni T
    Rev Epidemiol Sante Publique; 2001 Apr; 49(2):157-62. PubMed ID: 11319482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparative study on safety and immunogenicity between influenza subunit vaccine and split vaccine].
    Dong PM; Li YQ; Zheng TZ; Jia YP; Li F; Han TW; Qiao RX; Zhang BH
    Zhonghua Liu Xing Bing Xue Za Zhi; 2003 Jul; 24(7):570-3. PubMed ID: 12975010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Subvirion influenza vaccines: a subunit (glycoprotein) trivalent preparation Grippovac SE-AZh for immunization against influenza in children and persons with chronic pathology].
    Chumakov MP; Mel'nikova SK; Kusov IuIu; Kochetkov NK; Derevitskaia VA
    Vestn Akad Med Nauk SSSR; 1983; (12):21-9. PubMed ID: 6666316
    [No Abstract]   [Full Text] [Related]  

  • 10. Emerging data on the safety and efficacy of influenza vaccines in children.
    Vesikari T
    Pediatr Infect Dis J; 2008 Nov; 27(11 Suppl):S159-61. PubMed ID: 18955892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-lasting immunogenicity of a virosomal vaccine in older children and young adults with type I diabetes mellitus.
    Zuccotti GV; Scaramuzza A; Riboni S; Mameli C; Pariani E; Tanzi E; Zanetti A; Radaelli G
    Vaccine; 2009 Aug; 27(39):5357-62. PubMed ID: 19607951
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cost-effectiveness of live-attenuated influenza vaccine, trivalent in preventing influenza in young children attending day-care centres.
    Hibbert CL; Piedra PA; McLaurin KK; Vesikari T; Mauskopf J; Mahadevia PJ
    Vaccine; 2007 Nov; 25(47):8010-20. PubMed ID: 17936446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trial of split-product trivalent influenza vaccine in high-risk children.
    Yamada A; Yamawaki H; Tsuda N; Baba K; Yabuuchi H; Maeda A; Yamanishi K
    Biken J; 1982 Jun; 25(2):89-95. PubMed ID: 6753829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and immunogenicity of a prototype adjuvanted inactivated split-virus influenza A (H5N1) vaccine in infants and children.
    Nolan T; Richmond PC; Formica NT; Höschler K; Skeljo MV; Stoney T; McVernon J; Hartel G; Sawlwin DC; Bennet J; Ryan D; Basser RL; Zambon MC
    Vaccine; 2008 Nov; 26(50):6383-91. PubMed ID: 18801398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation of the reactogenic and immunogenic properties of the influenza subunit polyvalent vaccine Grippovac SE-AZh during the immunization of schoolchildren].
    Slepushkin AN; Obrosova-Serova NP; Feklisova LV; Bebisheva NI; Mel'nikova SK
    Vestn Akad Med Nauk SSSR; 1984; (1):75-9. PubMed ID: 6711101
    [No Abstract]   [Full Text] [Related]  

  • 16. Safety and immunogenicity of two subunit influenza vaccines in healthy children, adults and the elderly: a randomized controlled trial in China.
    Zhu FC; Zhou W; Pan H; Lu L; Gerez L; Nauta J; Giezeman K; de Bruijn I
    Vaccine; 2008 Aug; 26(35):4579-84. PubMed ID: 18602729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subunit influenza vaccines produced from cell culture or in embryonated chicken eggs: comparison of safety, reactogenicity, and immunogenicity.
    Reisinger KS; Block SL; Izu A; Groth N; Holmes SJ
    J Infect Dis; 2009 Sep; 200(6):849-57. PubMed ID: 19673652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and efficacy of vaccination against influenza in patients with rheumatoid arthritis.
    Elkayam O
    Clin Dev Immunol; 2006; 13(2-4):349-51. PubMed ID: 17162376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming?
    Walter EB; Neuzil KM; Zhu Y; Fairchok MP; Gagliano ME; Monto AS; Englund JA
    Pediatrics; 2006 Sep; 118(3):e570-8. PubMed ID: 16950948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and immunogenicity of a prepandemic influenza A (H5N1) vaccine in children.
    Vajo Z; Kosa L; Szilvasy I; Pauliny Z; Bartha K; Visontay I; Kis A; Tarjan I; Rozsa N; Jankovics I
    Pediatr Infect Dis J; 2008 Dec; 27(12):1052-6. PubMed ID: 18978514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.